Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut microbiota and endoxifen levels during tamoxifen therapy in postmenopausal breast cancer
NL-OMON53061Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tamoxifen in breast cancer, sponsored by Maastricht University Medical Center+. Primary endpoints: Microbiota composition before and during systemic hormone therapy and Relationship between microbiota composition and systemic estrogen and endoxifen levels. Started Oct 2017; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON53061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53061.